Agilent Technologies, Inc. $A Stock Holdings Increased by Lmcg Investments LLC

Lmcg Investments LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 7.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 93,891 shares of the medical research company’s stock after buying an additional 6,697 shares during the quarter. Lmcg Investments LLC’s holdings in Agilent Technologies were worth $10,702,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of A. Gabelli Funds LLC increased its holdings in shares of Agilent Technologies by 1.1% in the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after acquiring an additional 74 shares during the last quarter. Fiduciary Trust Co lifted its stake in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC lifted its stake in Agilent Technologies by 1.6% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after purchasing an additional 79 shares during the last quarter. Freestone Capital Holdings LLC boosted its holdings in Agilent Technologies by 2.0% in the fourth quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after purchasing an additional 84 shares during the period. Finally, Grove Bank & Trust boosted its holdings in Agilent Technologies by 5.5% in the fourth quarter. Grove Bank & Trust now owns 1,758 shares of the medical research company’s stock worth $239,000 after purchasing an additional 92 shares during the period.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on A shares. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Barclays lifted their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Robert W. Baird boosted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Piper Sandler initiated coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Finally, Royal Bank Of Canada started coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $160.88.

Agilent Technologies Price Performance

Shares of NYSE A opened at $128.77 on Thursday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $36.37 billion, a PE ratio of 25.86, a P/E/G ratio of 2.33 and a beta of 1.25. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The business’s fifty day moving average price is $124.91 and its two-hundred day moving average price is $125.73.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts expect that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is presently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.